Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Shares Outstanding (Diluted Average): 2023-2024

Historic Shares Outstanding (Diluted Average) for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to $11.3 million.

  • Artiva Biotherapeutics' Shares Outstanding (Diluted Average) rose 29.55% to $24.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.5 million, marking a year-over-year increase of 29.55%. This contributed to the annual value of $11.3 million for FY2024, which is 1302.54% up from last year.
  • According to the latest figures from FY2024, Artiva Biotherapeutics' Shares Outstanding (Diluted Average) is $11.3 million, which was up 1,302.54% from $802,747 recorded in FY2023.
  • Artiva Biotherapeutics' 5-year Shares Outstanding (Diluted Average) high stood at $11.3 million for FY2024, and its period low was $802,747 during FY2023.
  • Moreover, its 2-year median value for Shares Outstanding (Diluted Average) was $6.0 million (2023), whereas its average is $6.0 million.
  • Data for Artiva Biotherapeutics' Shares Outstanding (Diluted Average) shows a peak YoY soared of 1,302.54% (in 2024) over the last 5 years.
  • Artiva Biotherapeutics' Shares Outstanding (Diluted Average) (Yearly) stood at $802,747 in 2023, then soared by 1,302.54% to $11.3 million in 2024.